Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
January 17, 2020 Off

Global Epidermolysis Bullosa Therapeutics Market 2019-2023 | Evolving Opportunities With Fresenius and Novartis | Technavio

By BusinessWire

LONDON–(BUSINESS WIRE)–#Biotechnology–The global epidermolysis bullosa therapeutics market is poised to grow by USD 304.67 million during 2019-2023, progressing at a…

January 17, 2020 Off

Global Animal Medicine Market Opportunities And Strategies During the Forecast Period, 2019-2023 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Animal Medicine Global Market Opportunities And Strategies To 2023” report has been added to ResearchAndMarkets.com’s offering. Animal Medicine…

January 17, 2020 Off

Veterinary Pharmaceuticals Global Market Opportunities And Strategies To 2030 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Veterinary Pharmaceuticals Global Market Opportunities And Strategies To 2030” report has been added to ResearchAndMarkets.com’s offering. Veterinary Pharmaceuticals…

January 17, 2020 Off

MichBio Announces Creation of the “MichBio Diversity Network”

By BusinessWire

ANN ARBOR, Mich.–(BUSINESS WIRE)–#Bioscience–MichBio, the Michigan Bioscience Industry Association, is pleased to announce the creation of the “MichBio Diversity Network”…

January 17, 2020 Off

Global Type 1 Diabetes Drugs Market 2019-2023 | Evolving Opportunities with Eli Lilly and Merck | Technavio

By BusinessWire

LONDON–(BUSINESS WIRE)–#Biotechnology–Technavio has been monitoring the global type 1 diabetes drugs market since 2016 and the market is poised to…

January 17, 2020 Off

Alpha Holdings Comments on OncoSec’s Failure to Consider Superior Financing Proposal

By BusinessWire

OncoSec’s Refusal to Engage with Alpha Demonstrates Need for New Leadership Alpha Clarifies OncoSec Misstatements in OncoSec Response and Reaffirms…

January 17, 2020 Off

Cancer Testis Antigen 1- Pipeline Review, H2 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Cancer Testis Antigen 1 – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Summary…

January 17, 2020 Off

Serine Threonine Protein Kinase PLK1, Pipeline Review, H2 2019 – Leukemia, Breast Cancer, Hodgkin Lymphona & Rhabdomyosarcoma – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Serine Threonine Protein Kinase PLK1 – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering.…

January 17, 2020 Off

Ectonucleotide Pyrophosphatase Phosphodiesterase Family Member 2 – Pipeline Review, H2 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Ectonucleotide Pyrophosphatase Phosphodiesterase Family Member 2 – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s…

January 17, 2020 Off

Serine Threonine Protein Kinase Pim 1 – Pipeline Review, H2 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Serine Threonine Protein Kinase Pim 1 – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s…

Posts pagination

Previous 1 … 5,174 5,175 5,176 … 6,198 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Evommune Reports Third Quarter 2025 Financial Results and Provides Business Update

December 12, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine